Seres Therapeutics (MCRB)

Seres Therapeutics Financial Statements


Seres Therapeutics Financial Overview

Seres Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.141; its P/E ratio is -4.76; Seres Therapeutics is scheduled to report earnings on November 9, 2022, and the estimated EPS forecast is $-0.47. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 1.22M$ 1.49M$ 7.22M$ 126.72M$ 5.26M
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -63.23M$ -55.71M$ -49.26M$ 68.96M$ -47.60M
EBITDA$ -61.55M$ -54.14M$ -47.71M$ 70.45M$ -46.17M
Net Income Common Stockholders$ -64.73M$ -56.62M$ -50.00M$ 68.22M$ -48.33M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 195.79M$ 214.55M$ 242.80M$ 248.00M$ 253.62M
Total Assets$ 273.20M$ 319.89M$ 354.86M$ 396.29M$ 269.65M
Total Debt$ 33.30M$ 36.63M$ 39.47M$ 42.05M$ 43.93M
Net Debt$ -162.50M$ -177.92M$ -203.33M$ -205.95M$ -209.69M
Total Liabilities$ 250.14M$ 238.93M$ 223.35M$ 220.56M$ 168.58M
Stockholders Equity$ 23.06M$ 80.96M$ 101.07M$ 131.51M$ 143.71M
Cash Flow
Free Cash Flow$ -52.06M$ -69.39M$ -53.44M$ 123.65M$ -42.25M
Operating Cash Flow$ -49.90M$ -66.44M$ -51.86M$ 127.74M$ -39.70M
Investing Cash Flow$ 23.40M$ 12.97M$ 13.19M$ 25.11M$ 46.53M
Financing Cash Flow$ 130.00K$ 26.85M$ -780.00K$ 609.00K$ 585.00K
Currency in USD

Seres Therapeutics Earnings and Revenue History

Seres Therapeutics Debt to Assets

Seres Therapeutics Cash Flow

Seres Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis